4th July
Immunotherapy for Haematological Malignancies – The Future

Doubletree by Hilton Hotel, Redcliffe Way, Bristol BS16NJ

6 CPD points

Chair: Dr Stephen Robinson


  • Checkpoint inhibitors – what we have learnt from other malignancies
  • Incorporating checkpoint inhibitors into leukaemia and lymphoma
  • IMPACT transplant group and trials
  • New anti-B cell antibodies
  • BiTE technology and its application 
  • The antibody era dawns in multiple myeloma
  • Experience of CAR T cells in lymphoma and leukaemia
  • Challenges in delivering CAR T cell regionally
  • ECP in acute and chronic GVHD
  • Combination therapies with ECP
  • Potential of mesenchymal stem cells
  • Manipulating the ant-viral immune responses

……with plenty of time for discussion on future thoughts

To register contact aimee@hartleytaylor.co.uk
Places are limited so please register early to avoid disappointment

This programme has been put together by the Chair and an expert panel
– with thanks to Mallinckrodt who are providing sponsorship but have had no input into the programme development

Hartley Taylor Medical Communications Ltd
2, St George’s Court | St George’s Park
Kirkham | PR4 2EF